Mankind Pharma Pre-IPO - The Negatives - Recent Updates Weren't Great
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.
582 Views
Mankind Pharma Pre-IPO - The Positives - Diverse Portfolio with Steady past Performance
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.
495 Views
ECM Weekly (20th Jan 23) - HK Brokers, Wuxi, IQIYI, Anycol, Adani, WM Mot, LG Ene, AIn, Oasis, Perta
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
678 Views
ECM Weekly (15th Jan 2023) - 2022 Performance, 2023 Pipeline, Bilibili, HTHT, China Edu, CDP, Allied
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
642 Views
Aequitas 2023 Asia IPO Pipeline - India, ADRs, Korea, Japan and ASEAN
In this note, we will take a look at the Asia Pacific IPO pipeline for 2023, specifically for India, Asia-linked ADRs, Korea, Japan and ASEAN.
909 Views